Summer 2025

Software Engineer Intern

Robotics

Confirmed live in the last 24 hours

Neuralink

Neuralink

501-1,000 employees

Develops brain-computer interfaces for medical use

Compensation Overview

$31.50/hr

Austin, TX, USA

Texas Hourly Rate: $31.50/hr USD

Category
Robotics and Automation Engineering
Mechanical Engineering
Software Engineering
Required Skills
Rust
C/C++
Requirements
  • Evidence of exceptional ability in engineering or computer science
  • Experience in writing performant applications in a system language like C, C++, and Rust
  • Ability to work on mission-critical and safety-critical systems
  • Strong bias for action and first principles thinking
Responsibilities
  • Develop safety-critical software for the robot; you are responsible for contributing directly to surgery-ready software as an intern
  • Take ownership of a project that is integral to robot functioning from design to implementation under the guidance of a robot software team member
  • Jump on problems when they arise with a strong bias for action to support robot operation by non-software teams
  • Work across different engineering disciplines; your software may involve interactions with the mechanical, electrical, biological, and neuroscience teams
Desired Qualifications
  • Hands-on experience with robotics or high-reliability systems
  • Experience coding in Linux and debugging on Linux systems
  • Experience in computer vision
  • Experience in kinematics and motion planning
  • Experience working on medical robots
  • Experience working in a high-precision environment

Neuralink develops brain-computer interfaces (BCIs) that enable direct communication between the brain and external devices. Their main product, the N1 Implant, is a small, fully implantable device that allows users to control computers or mobile devices through their brain activity. The implant is powered by a wirelessly charged battery and uses custom chips to process neural signals, which are then sent to the Neuralink Application that translates these signals into commands. What sets Neuralink apart from competitors is its focus on precision implantation using a surgical robot that minimizes brain damage, ensuring a safer procedure. The company's goal is to restore autonomy to individuals with mobility issues or neurological disorders, while also appealing to those interested in enhancing their cognitive abilities.

Company Size

501-1,000

Company Stage

Series E

Total Funding

$1.3B

Headquarters

Fremont, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Neuralink raised $650 million in Series E funding to expand patient access.
  • The FDA granted 'breakthrough' status for Neuralink's speech restoration device.
  • Advancements in AI-driven neural signal decoding enhance Neuralink's device performance.

What critics are saying

  • Ethical concerns about brain-machine interfaces could lead to public backlash.
  • Competing technologies from companies like Synchron and Kernel may outpace Neuralink.
  • The complexity and cost of N1 Implant surgeries may limit accessibility.

What makes Neuralink unique

  • Neuralink's N1 Implant is a fully implantable, cosmetically invisible brain-machine interface.
  • The surgical robot developed by Neuralink ensures precise and minimally invasive implantation.
  • Neuralink's technology translates brain activity into computer commands, restoring autonomy to users.

Help us improve and share your feedback! Did you find this helpful?

Benefits

An opportunity to change the world and work with some of the smartest and the most talented experts from different fields.

Growth potential. We rapidly advance team members who have an outsized impact.

Excellent medical, dental, and vision insurance through a PPO plan; parental leave.

Flexible time off + paid holidays.

Equity + 401(k) plan.

Commuter Benefits.

Meals provided.

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

0%

2 year growth

0%
Tech Gist Africa
Jun 15th, 2025
Neuralink Raises $650M for Brain Implants

Neuralink, Elon Musk's neurotechnology company, raised $650 million in a Series E funding round. The funds will expand patient access, develop new brain implant devices, and enhance clinical trials. Neuralink's technology, tested in patients with severe paralysis, allows control of devices via thoughts. The FDA granted "breakthrough" status for its speech restoration device. Investors include ARK Invest, Sequoia Capital, and others. Neuralink's pre-funding valuation was approximately $9 billion.

Breaking The News
Jun 12th, 2025
Neuralink raises $649M in equity financing

Neuralink Corp., led by CEO Jared Birchall, has raised $649 million in an equity sale, as revealed in an SEC filing. The sale took place on May 30, 2025, with a minimum investment of $12,019 required from outside investors. The company did not disclose its revenue range.

CNBC
Jun 3rd, 2025
5 things to know before the stock market opens Tuesday

Neuralink, Elon Musk's brain tech startup, said it has closed a $650 million funding round led by ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners and others.

Goo News
Jun 3rd, 2025
Neuralink Raises $650M in Funding Round

Neuralink, led by Elon Musk, raised $650 million in a Series E funding round, with participation from at least 11 investment firms, including Ark Investment Management and Sequoia Capital. The company plans to use the funds to expand patient access and develop next-generation devices that enhance the connection between biological intelligence and AI. Neuralink is valued at $9 billion. Since the last funding round in August 2023, five patients with severe paralysis have used its devices.

ITmedia
Jun 2nd, 2025
Neuralink Raises $650M in Series E

Neuralink, founded by Elon Musk in 2016, announced on June 2 that it raised $650 million in a Series E funding round. Investors included ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital. The company is conducting clinical trials, including implanting brain chips in five severely paralyzed patients, and has started trials at major neurosurgical institutions. The funding will expand clinical trials and accelerate innovation in future devices connecting biology and AI.